InvestSMART

Cytopia Limited (ASX: CYT) - Share Price

DELISTED - Current share price for CYT : $0.130

CYT General Information +

ASX Code CYT
Website N/A
Industry/Sector Biotechnology
Market Cap ($M) n/a
CYT Share Price $0.130
Day High $0.000
Day Low $0.000
Last Close $0.130
CYT Share Price Movement - ( No change )
Prices as at 16:10, 18 Jan 2010
+Security prices are delayed by at least 20 minutes and are indicative only.

Cytopia Limited (CYT) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Cytopia Limited (CYT) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Cytopia Limited (CYT) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Cytopia Limited (CYT)
ORDINARY FULLY PAID
 Health Care - Suspension from Official Quotation 18 Jan 2010 1:07PM $0.130 $0.130 fallen by 0%
Cytopia Limited (CYT)
ORDINARY FULLY PAID
 Health Care - Dosing in Cytopia`s CYT387 clinical trial begins 24 Nov 2009 9:44AM $0.090 $0.130 risen by 44.44%
Cytopia Limited (CYT)
ORDINARY FULLY PAID
 Health Care - Update on Merger with YM BioSciences 2 Nov 2009 10:00AM $0.100 $0.130 risen by 30%
Cytopia Limited (CYT)
ORDINARY FULLY PAID
 Health Care - Cytopia opens fourth clinical centre for CYT997 glioma study 19 Oct 2009 12:25PM n/a $0.130 n/a
Cytopia Limited (CYT)
ORDINARY FULLY PAID
 Health Care - Cytopia merger with YM BioSciences Inc 6 Oct 2009 10:41AM $0.120 $0.130 risen by 8.33%
Cytopia Limited (CYT)
ORDINARY FULLY PAID
 Health Care - Cytopia achieves grant of further patent for JAK2 program 30 Sep 2009 8:45AM $0.120 $0.130 risen by 8.33%

CYT Directors

Name Position Start Date
Mr Andrew John Macdonald Chief Executive Officer, Managing Director 9 Jun 2006
Mr Robert (Bob) Charles Gregory Watson Director, Chairman 16 Jun 2003
Mr Mark Rowsthorn Non-Executive Director 12 Jan 1998
Dr Geoffrey N Vaughan Non-Executive Director 8 May 1998

Cytopia Limited (CYT) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
12 Jan 2010 MACDONALD, Andrew Buy Direct Shares 100,000 $0.115 $11,530.000
12 Jan 2010 MACDONALD, Andrew Sell Indirect Shares 165,000 $0.115 $19,000.000
12 Jan 2010 MACDONALD, Andrew Buy Direct Shares 165,000 $0.115 $19,000.000

See all changes in directors' interest & trades for Cytopia Limited (CYT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

CYT Management

Name Position
Ashley Arnott Chief Financial Officer,Company Secretary
Gregg Smith Drug, Development and Operations Director
Chris Burns Research Director

CYT Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (CYT). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
11,711,656 (13.83%) Mostia Dion Nominees Pty Ltd
10,359,377 (12.23%) Reash Pty Ltd
8,281,983 (9.78%) Asset Selection Advisors Pty Ltd
7,086,911 (8.37%) National Nominees Limited

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.